What are you searching for?

Sign in
Breaking News, Promotions & Moves

Ritter Pharmaceuticals Appoints CFO

John Beck joins with over 25 years of experience on the financial leadership side of the industry

By: Betsy Louda

, Contract Pharma

Ritter Pharmaceuticals has appointed John W. Beck as chief financial officer.

“We are pleased to add an executive of Mr. Beck’s caliber to our Company as we continue to expand and strengthen our management team during this exciting time of growth and product advancement,” said Michael D. Step, chief executive officer of the Company.  “John has an extensive track record of success at multiple life sciences companies including his role as CFO for Ardea Biosciences, Inc., which in 2012, was acquired by AstraZeneca for $1.26B.  Mr. Beck’s significant experience in public company management, his relationships within the investor community and his background in licensing and mergers and acquisitions will serve an important function for Ritter Pharmaceuticals as it moves into phase 3 clinical development with RP-G28 and prepares to commercialize this important asset, either alone or with partners, and build value for investors.”
 
“I am delighted to be joining the growing team of biotech professionals at Ritter Pharmaceuticals during this very important and exciting time,” said Mr. Beck.  “I look forward to working with them to expand and enhance the awareness of RP-G28’s potential to drive near-term shareholder value as well as its longer-term potential to help the millions around the world afflicted by this unmet medical need.”

Mr. Beck joins Ritter Pharmaceuticals with over 25 years of experience in leadership roles across finance, accounting and compliance, capital markets, fundraising, mergers and acquisitions and commercial operations in life sciences and high technologies companies.  Before joining Ardea, Mr. Beck spent 10 years with Metabasis Therapeutics Inc., as a co-founder and chief financial officer. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters